[{"address1": "1 Commonwealth Lane", "address2": "No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to conduct clinical trials for the GMP grade CTM-GDT. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 67, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 38143, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jieming  Zeng M.D., Ph.D.", "age": 51, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 102037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 35, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 39, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 36, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.93, "open": 0.9, "dayLow": 0.9, "dayHigh": 0.981, "regularMarketPreviousClose": 0.93, "regularMarketOpen": 0.9, "regularMarketDayLow": 0.9, "regularMarketDayHigh": 0.981, "payoutRatio": 0.0, "beta": -0.149, "forwardPE": -6.356, "volume": 45860, "regularMarketVolume": 45860, "averageVolume": 101132, "averageVolume10days": 45630, "averageDailyVolume10Day": 45630, "bid": 0.94, "ask": 1.9, "bidSize": 1, "askSize": 1, "marketCap": 11186921, "fiftyTwoWeekLow": 0.889, "fiftyTwoWeekHigh": 3.68, "allTimeHigh": 9.25, "allTimeLow": 0.889, "priceToSalesTrailing12Months": 15.327174, "fiftyDayAverage": 1.65006, "twoHundredDayAverage": 2.01562, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8712563, "profitMargins": 0.0, "floatShares": 3679298, "sharesOutstanding": 11733712, "sharesShort": 21050, "sharesShortPriorMonth": 27483, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0018000001, "heldPercentInsiders": 0.67355, "heldPercentInstitutions": 0.0019699999, "shortRatio": 0.52, "shortPercentOfFloat": 0.0061000003, "impliedSharesOutstanding": 11733712, "bookValue": 0.48056003, "priceToBook": 1.9839354, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -3672060, "trailingEps": -0.25, "forwardEps": -0.15, "enterpriseToRevenue": 11.937, "enterpriseToEbitda": -2.74, "52WeekChange": -0.62348175, "SandP52WeekChange": 0.14799047, "quoteType": "EQUITY", "currentPrice": 0.9534, "recommendationKey": "none", "totalCash": 2854958, "totalCashPerShare": 0.247, "ebitda": -3180003, "totalDebt": 489604, "quickRatio": 4.305, "currentRatio": 5.807, "totalRevenue": 729875, "debtToEquity": 6.779, "revenuePerShare": 0.063, "returnOnAssets": -0.22851999, "returnOnEquity": -0.42330003, "grossProfits": 675254, "freeCashflow": -2369023, "operatingCashflow": -3153215, "revenueGrowth": 1.01, "grossMargins": 0.92516, "ebitdaMargins": 0.0, "operatingMargins": -4.52169, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "corporateActions": [], "postMarketTime": 1768610034, "regularMarketTime": 1768597200, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.51613, "regularMarketPrice": 0.9534, "marketState": "CLOSED", "fiftyDayAverageChange": -0.69666004, "fiftyDayAverageChangePercent": -0.42220283, "twoHundredDayAverageChange": -1.06222, "twoHundredDayAverageChangePercent": -0.52699417, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "postMarketChangePercent": 4.877278, "postMarketPrice": 0.9999, "postMarketChange": 0.046499968, "regularMarketChange": 0.023400009, "regularMarketDayRange": "0.9 - 0.981", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 101132, "fiftyTwoWeekLowChange": 0.06440002, "fiftyTwoWeekLowChangePercent": 0.07244097, "fiftyTwoWeekRange": "0.889 - 3.68", "fiftyTwoWeekHighChange": -2.7266002, "fiftyTwoWeekHighChangePercent": -0.74092394, "fiftyTwoWeekChangePercent": -62.348175, "earningsTimestampStart": 1745870400, "earningsTimestampEnd": 1745870400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.25, "epsForward": -0.15, "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]